Average Co-Inventor Count = 4.37
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Avanir Pharmaceuticals (14 from 38 patents)
2. Samumed, LLC (7 from 115 patents)
3. Biosplice Therapeutics, Inc. (1 from 18 patents)
4. Avanir Pharmaceutials (1 from 1 patent)
23 patents:
1. 12134625 - Pyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereof
2. 10759799 - Indazole containing macrocycles and therapeutic uses thereof
3. 10533020 - 3-(3H-imidazo[4,5-B]pyridin-2-yl)-1 H-pyrazolo[3,4-C]pyridine and therapeutic uses thereof
4. 10183929 - 3-(benzoimidazol-2-yl)-indazole inhibitors of the Wnt signaling pathway and therapeutic uses thereof
5. 9815854 - 3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereof
6. 9546185 - 3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridine and therapeutic uses thereof
7. 8815897 - 1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof
8. 8450340 - [object Object]
9. 7514225 - Method for screening an agent that modulates activity of macrophage migration inhibitory factor
10. 7435737 - Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11. 7432374 - Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12. 7365200 - Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors
13. 7361760 - Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases
14. 7312220 - Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
15. 7312221 - Inhibitors of macrophage migration inhibitory factor and methods for identifying the same